On the 1st of November 2018, medicinal cannabis products were removed from schedule 1 and placed in schedule 2 of the Misuse of Drugs Regulations 2001. This change in the law has left patients, medical professionals and law enforcement perplexed about who should and who should not have access to medicinal cannabis. As access to medicinal cannabis expands in the coming years, the next generation of medical students will need to understand the Endocannabinoid System.
Drug Science believes that cannabis medicine should be an essential part of medical students’ education. Healthcare professionals do not feel comfortable prescribing something which they have little or no experience of treating patients with and which does not have the wealth of data from randomised controlled trials that is expected today. This is why Drug Science has developed an educational programme that covers the ‘must-have’ information surrounding medicinal cannabis. We intend to distribute these informative resources to all medical learning institutions. In the meantime, you can download our medicinal cannabis slides below.